Manufacturer record
Samay Pharma India Pvt. Ltd. Plot No 34-35 Industrial Area. Trilokpur Road: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Samay Pharma India Pvt. Ltd. Plot No 34-35 Industrial Area. Trilokpur Road (Himachal Pradesh) were declared Not of Standard Quality between July 2026 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
1 record linked to Samay Pharma India Pvt. Ltd. Plot No 34-35 Industrial Area. Trilokpur Road in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| R-Zara DSR Capsules | SC-08656Mfg 2026-01 · Exp 2027-12 | The sample does not pass the following test Assay Rabeprazole Sodium per capsule is 0.0 mg against claim of 20mg and Domperidone per capsule is 0.0mg against claim of 30mg.Assay | Gov Analyst Analyst. Haryana ChandigarhState lab | Jul 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.